A study found that psoralen could slow the progression of kidney cancer by inhibiting the expression of MKI67, PCNA, MMP2 and MMP9 as well as the proliferation, invasion, and migration of kidney cancer cells HTB-47 and CRL-1932 [103]. The gene discussed is MKI67; the disease is kidney cancer.